RespirAI enters into know-how agreement with Mayo Clinic for development of AI respiratory platform

RespirAI Medical is pleased to announce a collaboration with Mayo Clinic to develop a wearable AI-based home monitoring platform for respiratory diseases. This partnership aims to enhance patient care by closely monitoring the rehabilitation process of COPD patients who have undergone the Zephyr Valve procedure. This initiative strives to enhance patient outcomes and provide peace of mind to both patients and healthcare providers.

Stay tuned for more updates.